BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
CLSA maintains buy on Lupin
Lupin has planned a slew of generic launches in the US. Indian business growth is likely to rebound. New products will drive growth in Japan. Superior earnings growth will justify valuation. Target Rs 1,030.